Autoantibodies against the protease inhibitor calpastatin: A new risk factor for venous thrombosis?

Thrombosis and Haemostasis

Volumn 77, Issue 1, 1997, Pages 11-13

  Schlosser, Udo ^a   Lackner, Karl J ^a   Scheckenhofer, Christine ^a   Spannagl, Michael ^b   Spengel, Florentin A ^b   Hahn, Gabriele ^c   Lang, Bernhard ^a   Schmitz, Gerd ^a,d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALPASTATIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA LIBRARY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL PATIENT; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS;

EID: 0031055569     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1655728     Document Type: Article

References (18)

1. Dahlbäck B. Molecular genetics of venous thromboembolism. Ann Med 1995; 27: 187-92.
2. Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med 1993; 119: 819-27.
3. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-4.
4. 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
5. 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995; 4: 122-30.
6. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 341: 923-5.
7. Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Aoshima K, Ikeda T, Matsuda T. Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemost 1994; 71: 424-7.
8. Key NS. Toward an understanding of the pathophysiologic mechanism of thrombosis in the antiphospholipid antibody syndrome. J Lab Clin Med 1995; 125: 16-7.
9. Pötsch B, Kawamura H, Preissner KT, Schmidt M, Seelig C, Müller-Berghaus G. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. J Lab Clin Med 1995; 125: 56-65.
10. Kornberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1994; 153: 1328-32.
11. Croall DE, DeMartino GN. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 1991; 71: 813-47.
12. Despres N, Talbot G, Plouffe B, Boire G, Menard HA. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest 1995; 95: 1891-6.
13. Mimori T, Suganuma K, Tanami Y, Nojima T, Matsumara M, Fujii T, Yoshizawa T, Suzuki K, Akizuki M. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA 1995; 92: 7267-71.
14. Schlosser U, Lackner KJ, Scheckenhofer C, Schmitz G. Detection of autoantibodies against calpastatin, epitope mapping, and development of a specific peptide-ELISA. Clin Chem 1996; 42: 1250-6.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271-7.
16. Moore JC, Murphy WG, Kelton JG. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 1990; 74: 457-64.
17. Fox JEB, Austin CD, Reynolds CC, Steffen PK. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991; 266: 13289-95.
18. Wang KKW, Yuen P-W. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol Sci 1994; 15: 412-9.